Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine
Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine – TCTMD Study 1: Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination – New England Journal of Medicine Study 2: Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination – New England Journal of Medicine
The post Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine appeared first on Links Medicus.
Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients
Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients – Critical Care Commentary on Twitter Prone position in #COVID19, use & effect:➡️PP widely adopted, the more severe the respiratory failure, the more frequent the use➡️PP improved oxygenation in most (better V/Q matching?)➡️mortality of O2-Non-Responders significantly higher@Crit_Care […]
The post Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients appeared first on Links Medicus.
Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial – The Lancet Respiratory Medicine Commentary: Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 – The Lancet Respiratory Medicine Commentary on Twitter NEW Research— Early administration of inhaled budesonide reduced the likelihood of […]
The post Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19 appeared first on Links Medicus.
[Preprint] Pfizer vaccine less effective for SARS-CoV-2 variant B.1.351
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals – medRxiv Commentaries: South African variant may evade protection from Pfizer vaccine, Israeli study says – Reuters AND Israeli data shows South African variant able to ‘break through’ Pfizer vaccine – The Times of Israel Related: Another study indicates SARS-CoV-2 […]
The post [Preprint] Pfizer vaccine less effective for SARS-CoV-2 variant B.1.351 appeared first on Links Medicus.
Comprehensive Review | Pneumonia
Pneumonia – Nature Reviews Disease Primers (free for a limited period) Try this link if the above is paywalled.
The post Comprehensive Review | Pneumonia appeared first on Links Medicus.
Commentary | Distinguishing the real from the hyperglycemia: does COVID-19 induce diabetes?
Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes? – The Lancet Diabetes & Endocrinology
The post Commentary | Distinguishing the real from the hyperglycemia: does COVID-19 induce diabetes? appeared first on Links Medicus.
The NIH COVID-19 Treatment Guidelines Panel’s Statement on the Emergency Use Authorization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment of COVID-19
The COVID-19 Treatment Guidelines Panel’s Statement on the Emergency Use Authorization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment of COVID-19 – NIH COVID-19 Treatment Guidelines
The post The NIH COVID-19 Treatment Guidelines Panel’s Statement on the Emergency Use Authorization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment of COVID-19 appeared first on Links Medicus.
[Preprint] CoronaVac is 50% effective for reducing symptomatic SARS-CoV-2 infection after the first dose in the setting of high P.1 variant transmission in Brazil
Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study – medRxiv Commentary on Twitter (thread – click for more) New 50% efficacy study of Brazil-predominant vaccine CoronaVac (by Sinovac) in Manaus ?? among healthcare workers when #P1 ~75% dominant. Not a trial, but the study […]
The post [Preprint] CoronaVac is 50% effective for reducing symptomatic SARS-CoV-2 infection after the first dose in the setting of high P.1 variant transmission in Brazil appeared first on Links Medicus.
WHO Interim statement: A causal relationship between the AstraZeneca COVID-19 vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed
Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine – World Health Organization Commentary on Twitter (thread – click for more) ? Interim statement of the #COVID19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on the AstraZeneca vaccine https://t.co/p8XMMAiUne pic.twitter.com/7DMRNFxQsX — […]
The post WHO Interim statement: A causal relationship between the AstraZeneca COVID-19 vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed appeared first on Links Medicus.
Study: Outdoor transmission accounts for 0.1% of Covid-19 cases
Outdoor transmission accounts for 0.1% of State’s Covid-19 cases – The Irish Times Related: Systematic review: Outdoor transmission of SARS-CoV-2 and other respiratory viruses. “The odds of indoor transmission was very high compared to outdoors (18.7 times)”
The post Study: Outdoor transmission accounts for 0.1% of Covid-19 cases appeared first on Links Medicus.